Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

Rabheh Abdul Aziz, MD, MS

  • Outcome of serologically active clinically quiescent systemic lupus erythematosus in children. Rabheh Abdul Aziz (Principal Investigator). Rheumatology Research Foundation. $4,000. 3/1/2020-8/1/2020.

Stephanie Anzman-Frasca, PhD

  • Preventing Obesity Through Interventions During Infancy. Stephanie Anzman-Frasca (Principal Investigator). Pennsylvania State University. $59,798. 6/1/2018-3/1/2019.

Matthew Barth, MD

  • Targeting Oncogenic MicroRNAs in MYC Associated Aggressive B Cell Non-Hodgkin Lymphoma. Matthew Barth (Principal Investigator). Roswell Park Alliance Foundation. $70,000. 5/1/2019-4/1/2020.

Sara Berkelhamer, MD

  • Intraosseous Epinephrine: An Alternate Route of Drug Administration in Neonatal Resuscitation. Sara Berkelhamer (Principal Investigator). American Academy of Pediatrics: Neonatal Resuscitation Program. $50,000. 1/1/2019-12/1/2019.
  • Saving Lives at Birth. Sara Berkelhamer (Co-Investigator). USAID/Gates Foundation. $250,000. 7/1/2018-1/1/2020.
  • Targeted Antioxidant Therapy for the Treatment of BPD. Sara Berkelhamer (Principal Investigator). Wildermuth Research Foundation. $10,000. 5/1/2018-4/1/2019.

Kathleen Bethin, MD, PhD

  • Residual C-Peptide in Patients with Type 1 Diabetes. Kathleen Bethin (Principal Investigator). T1D Exchange. $9,545. 1/1/2012-1/1/2018.
  • Type 1 Diabetes TrialNet. Kathleen Bethin (Co-Investigator), Indrajit Majumdar (Co-Investigator), Teresa Quattrin (Principal Investigator). National Institutes of Health. $421,720. 9/1/2008-6/1/2018.

Melinda Cameron, MD

  • New York State Children‘s Environmental Health Center of Excellence. Melinda Cameron (Principal Investigator). Icahn School of Medicine at Mount Sinai. $125,000. 11/1/2017-10/1/2018.
  • Western New York Prevention Resource Center. Melinda Cameron (Principal Investigator). New York State Department of Health. $229,110. 1/1/1994-1/1/2021.

Praveen Chandrasekharan, MD, MS

  • A Novel Approach to Bradycardia during Preterm Neonatal Resuscitation Using an Ovine Model of Asphyxia. Praveen Chandrasekharan (Principal Investigator). ZOLL Foundation. $50,000. 7/1/2020-7/1/2022.
  • Effects of Chest Compression in a Neonatal Model of Asphyxia Induced Bradycardia. Praveen Chandrasekharan (Principal Investigator). Neonatal Resuscitation Program. $50,000. 1/1/2020-12/1/2022.
  • Optimizing Transition with Delayed Umbilical Cord Clamping and Supplemental Oxygen during Preterm Resuscitation with Perinatal Asphyxia. Praveen Chandrasekharan (Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $79,750. 7/1/2019-6/1/2021.
  • Rochester-Buffalo Neonatal Research Group. Praveen Chandrasekharan (Co-Investigator), Anne Marie Reynolds (Principal Investigator). University of Rochester. $300,025. 4/1/2016-3/1/2021.

Leonard Epstein, PhD

  • Enhancing Alternatives to Eating in Infants. Leonard Epstein (Co-Investigator), Kai Ling Kong (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,683,730. 8/1/2016-7/1/2021.
  • Can Reinforcing Alternatives to Food Prevent Weight Gain in Children?. Leonard Epstein (Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $1,723,154. 8/1/2016-7/1/2021.
  • The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care – CCC – Lead Application. Leonard Epstein (Principal Investigator), Teresa Quattrin (Co-Investigator). National Institutes of Health. $5,615,697. 6/1/2016-5/1/2021.
  • Evaluating the Impact of Tobacco Control Policies in a Rapidly Changing Nicotine Delivery Market. Leonard Epstein (Principal Investigator). Virginia Polytechnic Institute and State University. $35,041. 4/1/2016-3/1/2021.
  • Clinical Translational Science Award (CTSA). Leonard Epstein (Co-Investigator), John Canty, Jr. (Co-Principal Investigator), Margarita Dubocovich (Principal Investigator), Peter Elkin (Co-Investigator), Steven Fliesler (Co-Investigator), Alan Hutson (Co-Investigator), Gene Morse (Co-Investigator), Sanjay Sethi (Co-Investigator), Laurene Tumiel Berhalter (Co-Investigator). National Institutes of Health. $16,000,000. 1/1/2016-1/1/2019.
  • Sensitization of the Reinforcing Value of Food as a Predictor of Weight Change in Adolescents. Leonard Epstein (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $1,993,750. 1/1/2016-1/1/2021.
  • Delay Discounting as a Target for Self-Regulation in Prediabetes. Leonard Epstein (Co-Principal Investigator), Lucy Mastrandrea (Co-Investigator), Teresa Quattrin (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $2,417,153. 8/1/2015-7/1/2020.
  • Using Prospection to Improve Obesity Treatment. Leonard Epstein (Principal Investigator), Teresa Quattrin (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,191,299. 1/1/2015-12/1/2019.
  • Food Marketing Vulnerability and Increased Risk for Weight Gain in Adolescents. Leonard Epstein (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $58,812. 1/1/2015-1/1/2018.

Danielle Goetz, MD

  • A CF C3N Care Model of the Future: Proposal for Piloting a Learning Health System. Danielle Goetz (Principal Investigator). Cincinnati Children's Hospital Medical Center. $76,950. 6/1/2017-12/1/2018.
  • Implementation of the Depression and Anxiety Guidelines: Award for a Mental Health Coordinator. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation Therapeutics, Inc. $121,384. 1/1/2016-12/1/2018.
  • Additional Research Coordinator (ARC) Award. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation Therapeutics, Inc. $243,760. 1/1/2015-12/1/2018.
  • Success with Therapies Research Consortium. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation. $111,240. 8/1/2014-7/1/2018.
  • The EPIC Observational Longitudinal Assessment of Risk Factors For and Impact of Pseudomonas aeruginosa Acquisition and Early Anti-Pseudomonal Therapy in Children with Cystic Fibrosis. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation Therapeutics, Inc. $29,045. 3/1/2014-3/1/2019.

Oscar Gómez, MD, PhD

  • Studies on Emergent Diarrheagenic E. coli Pathogens. Oscar Gómez (Principal Investigator). National Institute of Allergy and Infectious Diseases. $675,282. 7/1/2016-11/1/2018.

Deepali Handa, MD, MBA

  • Use of Simulation to Facilitate Effective Parent-Provider Communication in Challenging Neonatal Scenarios. Deepali Handa (Co-Principal Investigator), Jayasree Nair (Co-Principal Investigator). American Academy of Pediatrics Disctrict II Section on Neonatal-Perinatal Medicine. 8/1/2019-7/1/2020.

Michelle Hartley-McAndrew, MD

Mark Hicar, MD, PhD

  • Comparing the COVID-19 antibody response of adults and children. Mark Hicar (Principal Investigator), Karl O. Yu (Co-Investigator). SUNY Research and Economic Development. $7,500. 5/1/2020-8/1/2020.
  • Defining the Epitopes of Anti-Kawasaki Disease Antibodies Identified from Circulating Plasmablasts During Kawasaki Disease. Mark Hicar (Principal Investigator). Wildermuth Foundation. $25,000. 5/1/2019-4/1/2020.
  • The Role of Non-Broadly Neutralizing Antibodies Targeting gp41 Structural Epitopes in Long-Term Nonprogression of HIV Infection. Mark Hicar (Principal Investigator). National Institute of Allergy and Infectious Diseases. $1,956,865. 2/1/2016-1/1/2021.

Lucy Holmes, MD, MPH

  • Project ASTHMA - Aligning with Schools to Help Manage Asthma. Lucy Holmes (Principal Investigator), Heather Lehman (Co-Investigator). University at Buffalo Clinical and Translational Science Institute. $49,650. 7/1/2018-6/1/2019.
  • Individual Development Awards Program. Lucy Holmes (Principal Investigator). United University Professions. $1,000. 1/1/2017-12/1/2017.

Shamim Islam, MD

  • Global Antimicrobial Resistance and the Environment. Shamim Islam (Principal Investigator). University at Buffalo. $64,500. 5/1/2018-6/1/2020.

James Jarvis, MD

  • Identifying Causal Variants in Juvenile Arthritis Using a Massively Parallel Reporter Assay. James Jarvis (Principal Investigator). National Institute of Arthritis and Musculoskeletal and Skin Diseases. $385,990. 9/1/2018-8/1/2020.
  • Developing Biomarkers for Juvenile Arthritis from Plasma Exosomes. James Jarvis (Principal Investigator). Wildermuth Foundation. $25,000. 6/1/2017-5/1/2018.
  • Interplay Between Genetics and Epigenetics in Polyarticular JIA. James Jarvis (Principal Investigator). Arthritis Foundation. $730,998. 12/1/2016-11/1/2018.
  • Plasma Exosomes in Juvenile Dermatomyositis. James Jarvis (Principal Investigator). Cure JM Foundation. $25,000. 7/1/2016-5/1/2018.
  • Arthritis Small Grant - Equipment. James Jarvis (Principal Investigator). Fraternal Order of Eagles. $3,344. 6/1/2015-5/1/2019.
  • Arthritis Small Grant - Gift Cards. James Jarvis (Principal Investigator). Fraternal Order of Eagles. $1,000. 6/1/2015-5/1/2019.

Kara Kelly, MD

  • Genetic Underpinnings of Ethnic Disparities in Bone Toxicities Between Hispanic and Non-Hispanic Children Treated for Acute Lymphoblastic Leukemia. Kara Kelly (Co-Principal Investigator). National Cancer Institute. $200,000. 12/1/2017-11/1/2019.
  • The Influence of Social Network Size, Composition and Function on Psychological Outcomes of Pediatric Cancer Caregiving: Relationships Across Time and Around Periods of Distress. Kara Kelly (Co-Investigator). National Cancer Institute. $722,488. 6/1/2017-6/1/2022.
  • A Comprehensive Assessment of Oral Chemotherapy Adherence in Pediatric ALL. Kara Kelly (Co-Principal Investigator). Roswell Park Alliance Foundation. $50,000. 6/1/2017-6/1/2018.

Jeremy Killion, MD

  • A Study Examining Visualization of the Larynx in Difficult Intubations Using a Specialized Device Called the “D-Blade”. Jeremy Killion (Co-Principal Investigator). Wildermuth Foundation. $4,929. 1/1/2017-12/1/2017.

Kai Ling Kong, PhD

  • Enhancing Alternatives to Eating in Infants. Kai Ling Kong (Co-Investigator), Leonard Epstein (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,683,730. 8/1/2016-7/1/2021.

Bree Kramer, DO

  • The Use of Near-infrared Spectroscopy in Children with Traumatic Brain Injury to Predict Adverse Events. Bree Kramer (Principal Investigator). Wildermuth Foundation. $9,600. 1/1/2018-1/1/2019.
  • Transmitted Lung Pressure Values with Biphasic Chest Cuirass. Bree Kramer (Principal Investigator). Kaleida Health Foundation. $4,000. 1/1/2018-1/1/2019.

Vasanth Kumar, MD

  • Regulation of PDE3 in the Pathobiology of Pulmonary Hypertension. Vasanth Kumar (Principal Investigator). National Heart, Lung, and Blood Institute. $234,132. 9/1/2017-8/1/2022.

Dennis Kuo, MD, MHS

  • Pediatrics Supporting Parents. Dennis Kuo (Principal Investigator). National Institute of Children’s Healthcare Quality. $20,000. 1/1/2019-4/1/2020.
  • Chapter Quality Network. Dennis Kuo (Principal Investigator). American Academy of Pediatrics. $100,000. 3/1/2018-2/1/2022.
  • DANY Ambulatory Care Training Enhancement Program Award. Dennis Kuo (Co-Investigator). New York State. $595,743. 1/1/2018-6/1/2021.
  • Community-Based Integrated Service Systems. Dennis Kuo (Principal Investigator). New York State Office of Children and Family Services. $406,000. 8/1/2017-7/1/2021.
  • Building Health Through Care Coordination for Children with Medical Complexity. Dennis Kuo (Principal Investigator). Lucille Packard Foundation for Children‘s Health. $68,903. 5/1/2017-8/1/2018.

Heather Lehman, MD, FAAAAI

  • A 5-Year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions. Heather Lehman (Principal Investigator). TARGET PharmaSolutions, Inc. 1/1/2020-12/1/2025.
  • Effects of infant egg consumption on child health and cognition development. Heather Lehman (Co-Investigator), Xiaozhong Wen (Principal Investigator). Egg Nutrition Center. $199,806. 12/1/2019-11/1/2021.
  • Single Arm, Open-Label, Multicenter, Registry Study of Revcovi (elapegademase-lvlr) Treatment in ADA-SCID Patients Requiring Enzyme Replacement Therapy. Heather Lehman (Principal Investigator). Leadiant Biosciences. 12/1/2019-12/1/2021.
  • A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety and Pharmacokinetics of Kedrion Intravenous Immunoglobulin 10 in PID Patients. Heather Lehman (Principal Investigator). Kedrion S.p.A. 1/1/2019-12/1/2020.
  • Project ASTHMA - Aligning with Schools to Help Manage Asthma. Heather Lehman (Co-Investigator), Lucy Holmes (Principal Investigator). University at Buffalo Clinical and Translational Science Institute. $49,650. 7/1/2018-6/1/2019.
  • Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators. Heather Lehman (Co-Investigator), Bruce Miller (Principal Investigator), Beatrice Wood (Principal Investigator). NIH/NHLBI. $3,987,363. 8/1/2015-7/1/2020.

Steven Lipshultz, MD

  • Research Scholar in Pediatric Cardiomyopathy. Steven Lipshultz (Principal Investigator). Children‘s Cardiomyopathy Foundation. 7/1/2019-6/1/2020.
  • First International Pediatric Cardio-Oncology Conference. Steven Lipshultz (Principal Investigator). Sofia's Hope. 7/1/2019-6/1/2021.
  • Sofia's Hope Coordinator. Steven Lipshultz (Principal Investigator). Sofia's Hope. 6/1/2019-5/1/2020.
  • Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy. Steven Lipshultz (Co-Principal Investigator). National Cancer Institute. 4/1/2019-3/1/2021.
  • Pediatric Cardiomyopathy Registry (PCMR). Steven Lipshultz (Principal Investigator). Children‘s Cardiomyopathy Foundation. 1/1/2019-1/1/2022.
  • Cardiac Toxicity in Perinatally HIV-Infected Adolescents and Young Adults, a Longitudinal Study. Steven Lipshultz (Principal Investigator). National Heart, Lung, and Blood Institute. 11/1/2018-5/1/2021.
  • Prognostic Significance of MicroRNA Expression in Children with Cardiomyopathy. Steven Lipshultz (Principal Investigator). National Heart, Lung, and Blood Institute. 11/1/2018-1/1/2022.
  • Pediatric HIV/AIDS Cohort Study (PHACS) Coordinating Center. Steven Lipshultz (Principal Investigator). Tulane University. 10/1/2018-7/1/2020.

Indrajit Majumdar, MBBS

Lucy Mastrandrea, MD, PhD

  • Delay Discounting as a Target for Self-Regulation in Prediabetes. Lucy Mastrandrea (Co-Investigator), Leonard Epstein (Co-Principal Investigator), Teresa Quattrin (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $2,417,153. 8/1/2015-7/1/2020.

Jayasree Nair, MD

  • Use of Simulation to Facilitate Effective Parent-Provider Communication in Challenging Neonatal Scenarios. Jayasree Nair (Co-Principal Investigator), Deepali Handa (Co-Principal Investigator). American Academy of Pediatrics Disctrict II Section on Neonatal-Perinatal Medicine. 8/1/2019-7/1/2020.

Teresa Quattrin, MD

  • Phase 2 SIMPONI to Arrest B-cell Loss in Type 1 Diabetes. Teresa Quattrin (Principal Investigator). Janssen Research and Development, LLC. $66,371. 1/1/2017-1/1/2019.
  • The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care – CCC – Lead Application. Teresa Quattrin (Co-Investigator), Leonard Epstein (Principal Investigator). National Institutes of Health. $5,615,697. 6/1/2016-5/1/2021.
  • Delay Discounting as a Target for Self-Regulation in Prediabetes. Teresa Quattrin (Co-Investigator), Leonard Epstein (Co-Principal Investigator), Lucy Mastrandrea (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $2,417,153. 8/1/2015-7/1/2020.
  • Using Prospection to Improve Obesity Treatment. Teresa Quattrin (Co-Investigator), Leonard Epstein (Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,191,299. 1/1/2015-12/1/2019.
  • Type 1 Diabetes TrialNet. Teresa Quattrin (Principal Investigator), Kathleen Bethin (Co-Investigator), Indrajit Majumdar (Co-Investigator). National Institutes of Health. $421,720. 9/1/2008-6/1/2018.

Anne Marie Reynolds, MD, MPH

  • Developmental Impact of NICU Exposures (DINE). Anne Marie Reynolds (Principal Investigator). National Institutes of Health. $5,300,000. 9/1/2016-8/1/2023.
  • Rochester-Buffalo Neonatal Research Group. Anne Marie Reynolds (Principal Investigator), Praveen Chandrasekharan (Co-Investigator). University of Rochester. $300,025. 4/1/2016-3/1/2021.
  • Neonatal Research Network. Anne Marie Reynolds (Co-Principal Investigator), Osman Farooq (Co-Investigator), Michelle Hartley-McAndrew (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. 4/1/2011-8/1/2022.

Beverly Schaefer, MD

  • Impact of Obesity on Laboratory Profiles, Treatment and Outcomes of Individuals with Type 1 Von Willebrand Disease and Low Von Willebrand Factor. Beverly Schaefer (Principal Investigator). American Thrombosis and Hemostasis Network. $50,000. 7/1/2018-6/1/2019.
  • Robert Long Career Development Award. Beverly Schaefer (Principal Investigator). Hemophilia Center of Western New York. $890,000. 1/1/2018-1/1/2022.

Sarah Ventre, MD, MPH

  • Environmental Health Scholar. Sarah Ventre (Principal Investigator). New York State Children’s Environmental Health Center. 11/1/2020-11/1/2022.

Xiaozhong Wen, PhD

  • CTSA Pilot: Lung and breast cancer prevention by an integrated intervention of maternal smoking cessation and breastfeeding. Xiaozhong Wen (Principal Investigator). NIH/NCATS. $45,000. 4/1/2020-3/1/2021.
  • Maternal Oxysterol Metabolism During Pregnancy. Xiaozhong Wen (Co-Investigator). NIH/NCATS. $40,000. 4/1/2020-3/1/2021.
  • Effects of infant egg consumption on child health and cognition development. Xiaozhong Wen (Principal Investigator), Heather Lehman (Co-Investigator). Egg Nutrition Center. $199,806. 12/1/2019-11/1/2021.
  • Snacking for Two (Impact of Changes in the Reinforcing Value of Food During Pregnancy in Smokers, Quitters, and Non-Smokers). Xiaozhong Wen (Co-Investigator). University at Buffalo. $10,000. 3/1/2019-6/1/2020.
  • Postpartum Smoking Relapse Prevention by Breastfeeding Promotion. Xiaozhong Wen (Principal Investigator). National Institutes of Health. $444,773. 8/1/2018-7/1/2020.
  • Socioeconomic disparities in early origins of childhood obesity and body mass index trajectories. Xiaozhong Wen (Principal Investigator). HRSA - Health Resources and Services Administration. $99,995. 7/1/2018-6/1/2020.

Karl O. Yu, MD, PhD, FAAP

  • Comparing the COVID-19 antibody response of adults and children. Karl O. Yu (Co-Investigator), Mark Hicar (Principal Investigator). SUNY Research and Economic Development. $7,500. 5/1/2020-8/1/2020.
  • Immunologic and clinical studies on perinatal hepatitis C viral infection. Karl O. Yu (Principal Investigator). Wildermuth Foundation. $35,000. 4/1/2020-3/1/2021.